
NAMS EPS Estimates
NewAmsterdam Pharma Company N.V.
$19.74
+$0.35(+1.81%)
39
Overall
50
Value
20
Tech
47
Quality
Market Cap
$2.37B
Volume
1.80M
52W Range
$17.90 - $42.21
Target Price
$51.50
NAMS EPS estimates: the consensus estimate for NewAmsterdam Pharma Company N.V.'s current fiscal year is -$1.48 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
NAMS EPS Estimates
- EPS estimate, current quarter
- $-0.44
- EPS estimate, next quarter
- $-0.54
- EPS estimate, current year
- $-1.48
- EPS estimate, next year
- $-2.29
- EPS growth, 3-year
- -21.46%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.72 |
| 2024 | $-2.56 |
| 2023 | $-2.15 |
| 2022 | $-0.96 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $19.74 | +1.8% | 1.80M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW